# The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

> **NCT05712603** · — · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 655 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DIAGNOSTIC_TEST:** FIB4-score
- **DIAGNOSTIC_TEST:** Vibration controlled transient elastography
- **DIAGNOSTIC_TEST:** Enhanced Liver Fibrosis test

## Key facts

- **NCT ID:** NCT05712603
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-10-15
- **Target enrollment:** 655 (ACTUAL)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05712603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05712603, "The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05712603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*